Astrana Health, Inc. (ASTH) — Stock Score Summary

Astrana Health, Inc. (ASTH) has a MoatMap StockRank of 96/100 based on Quality (50/100), Value (48/100), and Momentum (89/100) factor scores. The current signal is STRONG BUY. Astrana Health, a US healthcare company, has a low quality score (34). This suggests it does not possess the high ROIC, pricing power, or durable moat required for a quality compounder, and there is no specific macro tailwind to create an asymmetric opportunity.

Astrana Health, Inc. (formerly Apollo Medical Holdings) is an integrated healthcare delivery and technology company that provides value-based care management services, primarily to Medicare Advantage members. Its competitive moat is built on a physician-centric, integrated care model that leverages proprietary technology and data analytics to improve patient outcomes and reduce costs for complex populations. Astrana Health is a leading innovator in value-based care, focused on risk-bearing contracts and delivering comprehensive, coordinated care.

Key Financial Metrics

Price$37.85
Market Cap$1.9B
P/E (TTM)64.43
P/E (Forward)11.52
Price/Book2.40
Return on Equity5.7%
Return on Invested Capital5.6%
Debt/Equity184.46
Gross Margin10.7%
Operating Margin3.0%
Revenue Growth55.6%
Free Cash Flow$288M

Astrana Health, Inc. operates in the Medical Care Facilities industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Astrana Health, Inc.’s (ASTH) StockRank?
MoatMap’s StockRank for Astrana Health, Inc. (ASTH) is 96/100, with a Strong Buy signal. It is a composite of Quality (50), Value (48), and Momentum (89) factor ranks across MoatMap’s 19,000+ stock universe.
Does Astrana Health, Inc. have an economic moat?
Astrana Health, Inc. (ASTH) has a Quality factor score of 50/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Astrana Health, Inc. a buy, hold, or sell?
MoatMap’s current signal for Astrana Health, Inc. (ASTH) is Strong Buy, based on a StockRank of 96/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Astrana Health, Inc. in?
Astrana Health, Inc. (ASTH) operates in the Healthcare sector, specifically the Medical Care Facilities industry (United States).